Fmr LLC decreased its holdings in MAXIMUS, Inc. (NYSE:MMS) by 58.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,543,797 shares of the health services provider’s stock after selling 2,205,497 shares during the period. Fmr LLC owned about 2.40% of MAXIMUS worth $95,885,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. Millennium Management LLC increased its stake in shares of MAXIMUS by 194.9% in the 1st quarter. Millennium Management LLC now owns 51,876 shares of the health services provider’s stock worth $3,462,000 after purchasing an additional 34,286 shares in the last quarter. Legal & General Group Plc increased its stake in shares of MAXIMUS by 18.0% in the 1st quarter. Legal & General Group Plc now owns 69,267 shares of the health services provider’s stock worth $4,623,000 after purchasing an additional 10,543 shares in the last quarter. Principal Financial Group Inc. increased its stake in shares of MAXIMUS by 2.4% in the 1st quarter. Principal Financial Group Inc. now owns 288,467 shares of the health services provider’s stock worth $19,252,000 after purchasing an additional 6,866 shares in the last quarter. Xact Kapitalforvaltning AB increased its stake in shares of MAXIMUS by 23.2% in the 2nd quarter. Xact Kapitalforvaltning AB now owns 9,016 shares of the health services provider’s stock worth $560,000 after purchasing an additional 1,700 shares in the last quarter. Finally, Cambiar Investors LLC increased its stake in shares of MAXIMUS by 11.9% in the 2nd quarter. Cambiar Investors LLC now owns 70,574 shares of the health services provider’s stock worth $4,383,000 after purchasing an additional 7,482 shares in the last quarter. Institutional investors own 92.59% of the company’s stock.
In other MAXIMUS news, General Counsel David Francis sold 6,220 shares of the stock in a transaction dated Monday, October 1st. The shares were sold at an average price of $63.86, for a total transaction of $397,209.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Russell A. Beliveau sold 1,000 shares of the stock in a transaction dated Monday, October 1st. The shares were sold at an average price of $63.86, for a total transaction of $63,860.00. The disclosure for this sale can be found here. Insiders sold a total of 73,722 shares of company stock valued at $4,788,284 in the last quarter. 3.10% of the stock is currently owned by company insiders.
A number of brokerages have issued reports on MMS. Zacks Investment Research upgraded MAXIMUS from a “sell” rating to a “hold” rating in a research note on Tuesday, August 14th. Canaccord Genuity increased their price target on MAXIMUS from $64.00 to $67.00 and gave the stock a “hold” rating in a research note on Wednesday, October 10th.
Shares of MMS stock opened at $67.23 on Friday. MAXIMUS, Inc. has a 52-week low of $60.27 and a 52-week high of $72.71. The firm has a market capitalization of $4.11 billion, a price-to-earnings ratio of 22.19, a price-to-earnings-growth ratio of 2.35 and a beta of 0.97.
MAXIMUS (NYSE:MMS) last issued its quarterly earnings results on Thursday, August 9th. The health services provider reported $0.91 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.82 by $0.09. MAXIMUS had a return on equity of 21.51% and a net margin of 9.28%. The business had revenue of $597.90 million during the quarter, compared to analyst estimates of $591.91 million. During the same quarter in the prior year, the business posted $0.86 EPS. MAXIMUS’s revenue for the quarter was down .4% compared to the same quarter last year. As a group, equities analysts expect that MAXIMUS, Inc. will post 3.24 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 30th. Shareholders of record on Thursday, November 15th will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 1.49%. The ex-dividend date of this dividend is Wednesday, November 14th. This is a positive change from MAXIMUS’s previous quarterly dividend of $0.05. MAXIMUS’s dividend payout ratio is presently 5.94%.
ILLEGAL ACTIVITY WARNING: This report was published by American Banking News and is owned by of American Banking News. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2018/11/10/maximus-inc-mms-holdings-cut-by-fmr-llc.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.
Featured Article: Fundamental Analysis – How It Helps Investors
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.